​
​Background: Our US-based client, with a portfolio of cardiology/oncology interventional medical devices, planned to understand brand awareness among customers by hosting a conference.

Background: A leading medical device company is planning to launch a Point of Care (PoC) device for detecting infectious disease in Singapore. The company is looking for support with the key clinical stakeholder engagement strategy for their sales team.

​The Client
Our EU-based client is developing an AI-driven device for the diagnosis of a common diabetes-related condition. They intend to launch the device in India, which has the second highest diabetic population in the world. 

​The Business Problem
The client sought our help to devise a market access strategy to ensure the device’s integration into routine clinical practice upon its launch. They specifically wanted to know which pricing strategy to adopt considering the price-sensitive nature of the Indian market.​